ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
콜드체인 포장 시장 규모는 2025년에 322억 9,000만 달러에 이르고 예측 기간 중(2025-2030년) CAGR은 8.67%를 나타내 2030년에는 489억 3,000만 달러에 달할 것으로 전망됩니다.
식량농업기관은 매년 세계 13억 톤의 식량이 폐기되고 있는 것으로 추정되며, 이는 모든 국가, 모든 사회집단, 공급체인의 모든 단계에서 기여한 것입니다.
주요 하이라이트
다양한 정부에 의한 콜드체인 포장의 채용은 포장의 중요성을 보여줄 뿐만 아니라 시장 확대에 도움이 되고 있습니다.
콜드체인·부가가치·보존 인프라 계획은 농업 종사자부터 소비자에 이르기까지 원활하고 통합된 콜드체인과 보존 인프라 설비를 제공하는 것을 목적으로 하고 있습니다. 또한, 인도 정부가 발표한 통합 콜드체인·부가가치 인프라 계획에서는 관심이 있는 투자가는 정부가 사전에 설정한 비용·파라미터에 근거해, 프로젝트 비용의 35%로부터 50%의 보조금 또는 보조금을 받을 수 있습니다.
게다가 전자상거래의 급증을 고려하면, 단열포장은 밀 키트나 기타 신선식품품에 이르기까지, 소규모의 전자상거래나 식품택배업태로 호조인 매출이 전망됩니다.신선품이나 냉동품이 들어간 복수의 포장에는 단열 포장이 필요하기 때문에 엔데믹에 가장자리를 발한 행동양식의 변화에 따라 포장은 잠시 동안 옥외에 방치되게 되었습니다.
콜드체인 포장 솔루션은 신선품의 세계 거래 확대와 식료품과 건강 물자의 세계 공급에 필수적입니다.
식품 안전 근대화법(식품 보존을 위한 냉장 창고 요건)의 효과적인 실시 등, 엄격한 규제 증가가 시장의 성장을 뒷받침하고 있습니다. 또한, 의료기기나 제약 산업 등, 다양한 산업용도에서의 수요의 고조도, 세계의 콜드체인 포장 시장에 크게 공헌하고 있습니다.
그러나 최근에는 수급 격차의 확대에 의한 폴리스티렌 가격의 불안정성이 가격 상승으로 이어지고 있어, 이것은 예측 기간 중에도 계속될 것 같습니다.또한, 원료비의 상승이 최종 제품의 총 비용을 밀어 올리고 있습니다.
콜드체인 솔루션의 이용 효율은 COVID-19 이전에는 결코 최우선 사항이 아닙니다.팬데믹 동안 전 세계가 직면 한 가장 어려운 과제 중 하나는 모든 시민에게 예방 접종을 실시하기에 충분한 양의 백신을 제조하는 것이었지만, 이것은 백신을 썩지 않고 시민에게 확실히 또한 유행이 초래한 단락이나 기타 제한으로 인해 사업계획의 변경이나 택배 옵션의 도입을 강요받은 기업도 있었습니다.
콜드체인 포장 시장 동향
의약품 부문 성장으로 콜드체인 포장 시장 확대
Almac Pharma Services에 의하면, 개발중의 생물제제의 파이프라인은 온도감수성이 높아지고 있어 그 결과, 원약의 냉동 보존(-40--70℃)이 증가하고 있습니다.
고가치 의약품은 대부분 콜드체인을 통해 세계 유통망으로 출하됩니다. 따라서 의약품의 성장은 콜드체인 포장 시장을 촉진할 것으로 예상됩니다. 벨기에가 EU 회원국 중 영국 제품의 수출액이 가장 크고 거의 24억 3,000만 파운드에 이르고 있습니다.
또한 콜드체인 포장 시장은 의료 산업에서 사용되는 보냉 의약품 수요의 지속적인 성장에 의해 직접 영향을 받고 있습니다.
또한, 콜드체인 포장의 재료 사용에 대한 정부 규제의 영향도 시장에 나타났습니다. 온도 관리 포장에 대한 관심은 규제와 규격의 변화에도 영향을 받고 있습니다.
유럽이 가장 큰 시장 점유율을 차지
콜드체인 포장 시장에서는 유럽이 큰 점유율을 차지하고 있습니다.
많은 기업들이 경쟁을 이기기 위해 혁신적인 콜드체인 포장 기술을 창출하기 위한 투자와 연구개발 활동에 주력하고 있습니다. Packaging의 강점을 조합하는 것으로, 관련성이 높아 환자의 안전성을 향상시키는 미래의 포장 솔루션을 제공하는 것을 목적으로 하고 있습니다.
또한 유럽 기업은 콜드체인 솔루션을 도입하여 의약품 포장 및 보관 강화에 있어 진보를 창출하고 있습니다. 는 의료 서비스의 제공 범위를 확대했습니다. 샤프는 수탁 포장과 임상 공급 서비스에 있어 유명한 진출기업입니다., 이미 있는 임상용 보관·유통 기능이 강화되었습니다. 이미 초기 포장과 라벨링은 완료하고 있습니다. 스로서의 안구건조증스 보관 등, 모든 임상 서비스를 시설로부터 제공할 수 있습니다.
게다가 유럽을 거점으로 하는 기업의 대부분은 유럽 전역에서 제약·생명과학 기업의 수가 증가하고 있기 때문에 국제적인 리치를 넓히기 위해 기업 성장에 임하고 있습니다. 예를 들어, 2022년 2월 도이치 포스트 DHL 그룹의 물류 회사인 DHL Supply Chain의 생명 과학 및 헬스케어(LSHC) 부문은 올해 4억 달러 이상을 투자하여 제약 및 의료 기기 유통 네트워크 공간을 27%, 약 300만 평방 피트 추가 확장할 것이라고 발표했습니다.
콜드체인 포장 산업 개요
콜드체인 포장 시장은 소수의 기업이 큰 점유율을 차지하고 있기 때문에 적당히 부문 화되어 있습니다.
2022년 3월 - 콜드체인테크놀로지스는 생명과학 분야에 친환경적이고 도로변 재활용이 가능한 열 포장 솔루션을 공급하는 저명한 업체인 패키징 테크놀로지 그룹(Packaging Technology Group, LLC)을 인수했다고 발표했습니다. 회사는 중요한 지속 가능한 기술에 대한 투자를 확대하고 세계 고객에게 폭넓은 혁신적인 솔루션을 제공할 수 있습니다.
The Cold Chain Packaging Market size is estimated at USD 32.29 billion in 2025, and is expected to reach USD 48.93 billion by 2030, at a CAGR of 8.67% during the forecast period (2025-2030).
The Food and Agriculture Organization estimates that 1.3 billion metric tonnes of food are wasted worldwide each year, accounting for contributions from every country, every societal group, and every step in the supply chain. The instability in the food system brought on by the COVID-19 epidemic made an already terrible loss even more painful.
Key Highlights
The adoption of cold chain packaging by various governments not only demonstrates the importance of the packaging but also aids in market expansion. For instance, in June 2022, the "Scheme of Cold Chain, Value Addition and Preservation Infrastructure" plan, which is largely funded by the Indian government, reported that the government provides funding for investments in the cold chain, including processing.
The Scheme of Cold Chain, Value Addition, and Preservation Infrastructure aims to provide seamless, integrated cold chain and preservation infrastructure facilities from the farm gate to the consumer. With a focus on developing farm-level cold chain infrastructure, the strategy offers project planning flexibility. Additionally, an interested investor may receive a grant or subsidy of 35% to 50% of the project cost based on previously established cost parameters by the government under the scheme for integrated cold chain and value addition infrastructure released by the Government of India.
Further, considering the spike in e-commerce, insulated packaging is expected to see strong sales with smaller e-commerce and food delivery formats across meal kits and other perishable food and beverage items. As multiple packages containing fresh and frozen items require good insulation, the pandemic-led behavioral change has led to packages being left outdoors for some time. Hence, the pandemic is further expected to witness a significant increase in the demand for cold chain packaging solutions.
Cold chain packaging solutions are essential to the growth of the global trade in perishable products and the worldwide availability of food and health supplies. The rise in consumer demand for perishable food items, growth of international trade due to trade liberalization, and expansion of the organized food retail industry are some of the factors driving the growth of the market.
Increasing stringent regulations, such as the effective implementation of the Food Safety Modernization Act (cold storage warehouse requirement to preserve food), drive the market's growth. Additionally, the rising demand from various industrial applications, such as the medical devices and pharmaceutical industries, are significant contributors to the global cold chain packaging market.
However, in recent times, instability in polystyrene prices, due to the increased gap between demand and supply, has led to a price surge, which is likely to continue during the forecast period. Moreover, the escalated cost of raw materials is boosting the overall cost of the final product.
Efficiency in using cold chain solutions was never a top priority before COVID-19. While during the pandemic, one of the most difficult challenges facing the globe was to produce enough vaccines to immunize every citizen, which was a huge undertaking to ensure that vaccines were distributed to citizens without spoiling them. Due to lockdowns and other limitations brought on by the outbreak, some businesses were forced to alter their business plans and implement home delivery options. Additionally, this called for efficient cold chain logistics solutions. Demand increased even more due to growing consumer awareness and the necessity of upholding essential quality standards.
Cold Chain Packaging Market Trends
Growth in Pharmaceutical Sector to Augment the Cold Chain Packaging Market
According to Almac Pharma Services, the pipeline of biological drugs in development is becoming more temperature-sensitive, resulting in an increase in the storage of bulk drug substances at frozen temperatures (-40 to -70 °C). The company adds that labeling, packing, and distributing cell and gene therapy products often requires products to be stored and processed at ultra-low temperatures (-20 to -80 °C), with the products only being defrosted immediately before use.
The high-value pharmaceutical products are mostly shipped via the cold chain across the entire distribution network worldwide. Thus, pharmaceutical growth is anticipated to propel the cold chain packaging market. According to International Trade Center, the value of exports of pharmaceutical products from the United Kingdom to the European Union show that in that year, Belgium was the EU member with the largest export value of such British goods, amounting to almost 2.43 billion British pounds. The significant export value represents that the packaging conditions may choose cold chain packaging to adapt to dynamic conditions such as temperature, mode of transportation,etc.
Moreover, the cold chain packaging market is directly influenced by the continuous growth in demand for cold storage medicinal products used in the healthcare industry. Regionally, the cold chain packaging market is dominated by Europe and North America region. This is due to the high number of biopharmaceuticals imports & exports in the countries in Europe and North America. These regions are also the innovators for the improvement in shipping and warehousing of pharmaceutical products.
Further, the market is witnessing an effect due to government regulations regarding the use of materials in cold chain packaging. There is also a strong demand for more sustainable designs, including re-use programs, to reduce the carbon footprint. The interest in temperature-controlled packaging is also impacted by changing regulations and standards. For instance, ISTA's (International Safe Transit Association) temperature profiles were altered within the past five years. Such changes are anticipated to affect the market.
Europe to Hold the Largest Market Share
Europe occupies the major share in the cold chain packaging market. The market is expected to grow significantly in the forecast period owing to continuous growth in demand for cold storage medicinal products used in the healthcare industry.
Many companies have focused on investments and research and development activities on creating innovative cold chain packaging technologies to stay ahead of the competition. For instance, in May 2022, Essentra Packaging collaborated with AMD to create a new generation of Time Temperature Indicators (TTIs), a smart packaging technology for the pharmaceutical industry. The collaboration by the United Kingdom-based companies aims to provide future packaging solutions that are relevant and improve patient safety by combining the strengths of AMD and Essentra Packaging.
Additionally, European businesses are creating advancements in enhancing pharmaceutical packaging and storage by implementing cold chain solutions. For instance, in July 2022, the Netherlands' Sharp plant in Heerenveen increased the range of healthcare service offerings. Sharp is a prominent player in contract packaging and clinical supply services. Labeling and secondary packaging services have been added to the site to accommodate open and randomized clinical trials, enhancing the clinical storage and distribution capabilities already there. Already finished are the initial packaging and labeling procedures. Sharp can now provide a full range of clinical services out of the facility, including secondary packaging between temperatures of -80°C and -80°C, storage between 2 and 8°C, and on dry ice as QP release for clinical trial materials. The website's customers can get help with regulatory issues to release and distribute items in Europe.
Furthermore, many European-based businesses are engaged in corporate growth to broaden their reach internationally due to the growing number of pharmaceutical and life sciences enterprises across the continent. For instance, in February 2022, the life sciences and healthcare (LSHC) sector of the Deutsche Post DHL Group's logistics company, DHL Supply Chain, announced that it would invest more than USD 400 million this year to expand its pharmaceutical and medical device distribution network footprint by 27 percent or nearly 3 million additional square feet. The new buildings will have complete licensing, temperature-controlled space that satisfies pharmaceutical storage needs, and integrated solutions that can handle the packing and managed transportation.
Cold Chain Packaging Industry Overview
The cold chain packaging market is moderately fragmented due to a few players having a significant share in the market. Some of the major players are Cold chain Technologies, Sonoco Thermosafe, Sofrigram, Softbox Systems, Cryopak, Sealed Air Corporation, DGP Intelsius LLC., Amcor Plc, among others.
March 2022 - The acquisition of Packaging Technology Group, LLC, a prominent supplier of environmentally friendly, curbside-recyclable thermal packaging solutions for the life sciences sector, was announced by Cold Chain Technologies, LLC. Through this agreement, the Packaging Technology Group Company will be able to make more investments in vital sustainable technologies and provide its customers worldwide with a wider range of innovative solutions.
December 2021 - Recycold Cool Solutions BV, a producer of eco-friendly cool packs, has been acquired by Ranpak Holdings Corp. Recycold Cool Packs, which are constructed from a drain-safe, plant-based gel, unlike conventional cool packs, have been added to increase the variety of Ranpak's Cold Chain packaging solutions.
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
4.1 Market Overview
4.2 Industry Value Chain Analysis
4.3 Industry Attractiveness - Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitutes
4.3.5 Intensity of Competitive Rivalry
4.4 Market Drivers
4.4.1 Growth in Pharmaceutical and Healthcare Sector to Boost the Market
4.4.2 Increasing Consumer Demand for Perishable Food
4.5 Market Restraints
4.5.1 Government Regulations Regarding the Use of Materials with Low Carbon
4.5.2 Rising Cost of Raw Material
4.6 Assessment of Impact of COVID-19 on the Market